Nanavati Super Speciality Hospital in collaboration with Parkinson’s Center of Excellence, Kings College, London, launch the revolutionary new modality for the treatment of Parkinson’s for the first time in India Apomorphine PEN & PUMP launched in India Parkinson’s disease is one of the common neurodegenerative disease affecting people over the age of 55 years.
Parkinson’s is characterized by slowness, stiffness and tremors and is a special neurodegenerative disorder with very few therapeutic options available. In India, the prevalence of this disease advances between the age of 70-79. It is caused by dopamine deficiency which is a chemical neuro transmitter in the brain mainly in the centers controlling the mobility. Nanavati Super Speciality Hospital in association with Kings College, London, have launched the revolutionary treatment that will change the way Parkinson’s has been treated in India. Apomorphine PEN & PUMP, the treatment that will radically change the life of a Parkinson’s patient will now be available in India. The treatment was launched by the Health Minister of Maharashtra, Dr. Deepak Sawant and Guest of Honour -Paresh Rawal, Actor and Member of Parliament.
Apomorphine is a highly selective dopamine receptor stimulator, which promotes the release of dopamine in the brain from the nerve cells, that is otherwise absent. Dr. Rajendra Patankar, COO, Nanavati Super Speciality Hospital, speaking on the launch of the radical treatment of Parkison’s says, “Apomorphine is a revolutionary breakthrough to treat the Parkinson’s patients. Associating with the prestigious King’s College, London, has been an honor for us. As a healthcare provider, we would like to commit ourselves to improve the healthcare in India and bring in such great advancements in the field on medicine to India.”
The PEN & PUMP treatment is an effective alternative for those who do not want to undergo Deep brain stimulation (DBS). According to Dr. Neeta Shah, Consultant Parkinson’s Disease and Movement Disorders Specialist, Nanavati Super Specialty Hospital, Mumbai, “To treat Parkinson’s disease in the advance stage is a challenge . Patient suffer from progression in symptoms and side effects of increasing dosages of standard medications. We need some novel way to treat this disease. This treatment will be a boon for such patients.”
Movement Disorders Specialist from London, Dr. Vinod Metta, leads one of the biggest set of patients on Apomorphine in United Kingdom, speaks about the launch, “Apomorphine pens provide relief to the patients within a couple of minutes and the usage is similar to insulin pens.”